IFCT-2105 lurbiclin real-world effectiveness and treatment sequences in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) who received lurbinectedin as part of the French Early Access Program (EAP-ATU).

  • Etude concernée: IFCT-2105
  • Auteurs / Authors: Nicolas Girard, Florian Guisier, Aurélie Swalduz, Sylvie Van Hulst, Eric Pichon, Pernelle Lavaud, Laurent Greillier, Angelica Tiotiu, Anne Madroszyk, Olivier Bylicki, Anthony Canellas, Laure Belmont, Maeva Zysman, Pierre-Alexandre Hauss, Benoit Godbert, Clarisse Audigier-Valette, Cléa Lebreton, Franck Morin, Virginie Westeel
  • Journal / Conference: ASCO
  • Année / Year: 2023
  • PMID: Poster session
  • Lien vers la publication: https://meetings.asco.org/abstracts-presentations/223135
  • PDF: LURBICLIN_poster_ASCO_V3_12MAY2023.pptx_002.pdf